Add like
Add dislike
Add to saved papers

School-based water promotion program associated with lower overweight prevalence

2 Minute Medicine 2023 August 10

1. Implementation of ‘Water First’, a program consisting of classroom lessons, water promotion, and water stations, was associated with a lower increase in overweight prevalence compared to the control group.

2. No significant change was seen in obesity prevalence in schools exposed to the intervention.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Childhood obesity is a major risk factor for the development of chronic illnesses in adulthood. Given that sugar-sweetened beverages (SSBs) are linked to childhood overweight and obesity, this cluster-randomized control trial sought to examine if a school-based drinking water promotion program could address overweight prevalence in elementary school students by reducing SSB consumption. 18 public elementary schools that served low-income and ethnically diverse children were included in the study. ‘Water First’, a program consisting of classroom lessons, water promotion, and water stations, was implemented in 9 schools, while the other 9 served as controls. 7 and 15 months after the start of the study, participants’ BMI and self-reported dietary caloric intake were measured. At 15 months, there was a significantly lower increase in overweight prevalence in the intervention group (0.5%) compared to the control group (3.7%). However, there was no significant difference in obesity prevalence between the two groups. Intervention participants drank more water after 7 and 15 months of the program. This study adds to the limited body of evidence that supports school-based water promotion as a cost-effective intervention against overweight in childhood. However, the feasibility of implementing this labor-intensive program on a large scale is questionable, and therefore its ability to impact real-world health outcomes is difficult to ascertain. Nonetheless, this useful study demonstrates that targeting the consumption of SSBs is a promising tool to address the growing problem of childhood overweight and obesity.

Click to read the study in Pediatrics

Relevant Reading: Effect of a school-based water intervention on child body mass index and obesity

In-Depth [randomized control trial]: 1262 children across 18 schools were randomized to either the intervention (n = 680, 9 schools) or the control group (n = 582, 9 schools). After losing participants to follow-up, data from 548 participants in the intervention group and 510 participants in the control group were analyzed. The participants’ mean age was 9.6 years (SD = 0.4), 47.4% were female, and 69.4% qualified for free or reduced-price meals. BMI percentile, mean BMI, BMI z-score, and prevalence of overweight, obesity, and severe obesity were calculated. From baseline to 7 months, no significant changes were seen in the proportion of overweight participants between the intervention and control groups (-0.4%) (adjusted ratio of ORs: 0.7 [CI 0.2-0.9] P = 0.68). At 15 months, intervention participants had significantly lower increases in overweight prevalence (0.5%) when compared to control participants (3.7%), as well as significantly lower change in overweight prevalence (adjusted ratio of ORs: 0.1 [CI 0.03-0.7] P = 0.017) when compared to control participants. At both follow-ups, the intervention had no effect on the prevalence of obesity or severe obesity. Dietary caloric intake was calculated from 24-hour dietary recalls at baseline and at 7 months, and between-group analyses showed no statistically significant changes over time. To measure the frequency of water consumption, 1-week beverage frequency questionnaires were used. Intervention participants, when compared to control participants, displayed a significantly greater increase in frequency of water consumption at 7 months (1 time/day for intervention participants, -0.5 time/day for control participants; adjusted percent difference in change: 23.2% [CI 13.1-34.2]) and at 15 months (0.1 time/day for intervention participants, -0.9 time/day for control participants; adjusted percent difference in change: 14.7% [CI 4.5-25.9]). Intervention participants also displayed a significantly greater decrease in the frequency of SSB consumption at 7 months (-1.1 time/day) in comparison to control participants (-0.7 time/day). This change was not statistically significant within the 18 schools that completed data collection, but sensitivity analyses that estimated a full sample including an additional 8 schools projected this greater decrease in frequency of SSB consumption in intervention participants to be significant.

Originally Published By 2 Minute Medicine®. Reused on Read by QxMD with permission.

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Add to Saved Papers

Get 1-tap access

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app